Periodical (Journal)

  1. PSIref
  2. Periodicals
ISSN  :   1175-3277 ( Print )   |   1179-187X ( Online )   Active

Journal American Journal of Cardiovascular Drugs

Aim & Scope

Promoting rational therapy within the discipline ofcardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents. Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations. [1]

Go to Website

2024
7 RESULTS in 14 msec
2024-07-19

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

J Kalinski , B Xu , R Boyd , ... , M Desai

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00667-z

0 33

2024-07-17

Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention.

A Greco

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00666-0

  Comment
0 17

2024-07-08

The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure

M Sheikh-Taha

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00663-3

  0 15

2024-07-05

Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial.

E Khani , N Aslanabadi , K Mehravani , ... , T Entezari-Maleki

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00662-4

  0 29

2024-07-04

Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis.

Y Soliman , M Abuelazm , BE Amer , ... , H Hassaballa

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00661-5

  1 45

2024-06-24

The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis.

E Fatima , Z Qureshi , M Khanzada , ... , F Altaf

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00654-4

  0 27

2024-06-23

Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience.

P Severino , A D'Amato , S Prosperi , ... , CD Vizza

American Journal of Cardiovascular Drugs , 2024

10.1007/s40256-024-00660-6

  0 29